Colorado joined the federal government and 38 other states and territories to settle with Pfizer over alleged migraine drug ...

Dividend stocks have remained a focal point for investors, especially amid market volatility and the growing need for steady ...

CNS-focused biopharma Axsome Therapeutics has won US Food and Drug Administration (FDA) approval for Symbravo (meloxicam and rizatriptan) for the acute treatment of migraine with or without aura in ...